Clinical effectiveness of platelets in additive solution treated with two commercial pathogen‐reduction technologiesPaolo Rebulla, Giuliano Grazzini, Serelina Coluzzi et al.|Transfusion|2017Cited by 75
Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patientsEmanuela Cova, Mauro Ceroni, Paolo Bongioanni et al.|Neurochemistry International|2010Cited by 56
Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to α‐interferon treatment in patients with chronic hepatitis CA. Airoldi, Giovambattista Pinzello, Claudio Zavaglia et al.|European Journal of Immunogenetics|2004Cited by 15